In a study of CD133+ xenograft‐carrying immunodeficient mice, treatment with carbon nanotubes conjugated to an anti‐CD133 monoclonal antibody followed by near‐infrared laser irradiation efficiently targeted and destroyed GBM CSCs in vitro and in vivo.220. The gene discussed is PROM1; the disease is glioblastoma.